 Connection
Neil Aggarwal to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Neil Aggarwal has written about Dose-Response Relationship, Drug.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.074 |
|
|
|
-
April MD, Butler H, Demasi SC, Aggarwal NR, Andrea LJ, Barker AB, Barnes CR, Brainard JC, Brewer JM, Driver BE, Gaillard JP, Gandotra S, Ghamande SA, Gibbs KW, Herbert JT, Hughes CG, Janz DR, Joffe AM, Khan A, Kramer PJ, Latimer AJ, Mitchell SH, Moskowitz AL, Page DB, Prekker ME, Resnick-Ault D, Self WH, Smith LM, Sottile PD, Stempek SB, Trent SA, Vonderhaar DJ, Walker JE, White HD, Semler MW, Casey JD, Schauer SG, Ginde AA. Rocuronium dose and first-attempt intubation success in the critically ill: secondary analysis of two multicenter trials. Am J Respir Crit Care Med. 2026 Aug 01; 212(8):1740-1749.
Score: 0.044
-
Casey JD, Johnson NJ, Semler MW, Collins SP, Aggarwal NR, Brower RG, Chang SY, Eppensteiner J, Filbin M, Gibbs KW, Ginde AA, Gong MN, Harrell F, Hayden DL, Hough CL, Khan A, Leither LM, Moss M, Oldmixon CF, Park PK, Reineck LA, Ringwood NJ, Robinson BRH, Schoenfeld DA, Shapiro NI, Steingrub JS, Torr DK, Weissman A, Lindsell CJ, Rice TW, Thompson BT, Brown SM, Self WH. Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19. Ann Am Thorac Soc. 2020 09; 17(9):1144-1153.
Score: 0.029
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|